Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.

Comirnaty (tozinameran) - Pfizer, BioNTech

Kostaive (ARCT-154) - Arcturus Therap

http://www.ncbi.nlm.nih.gov/pubmed/39460327

Aimee Ferraro; Cheng Chang; Ethan Settembre; Jean Marie Pivette; Joaquin F Mould-Quevedo; John Youhanna; Josephine van Boxmeer; Pascal Crépey; Sankarasubramanian Rajaram; Van Hung Nguyen

Oct 27, 2024